A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Completed · Phase 2
Conditions studied: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
In brief
The purpose of this study is to determine which patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib.
Key facts
- Study ID
- NCT01891344
- Run by
- pharmaand GmbH
- People needed
- 491
- Starts
- 2013-10-30
- Expected to finish
- 2021-09-28
- Last updated by the study team
- 2023-06-12
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Arizona Cancer Center — Tucson, Arizona, United States
- Saint Jude Heritage Medical Center — Fullerton, California, United States
- University of California Los Angeles — Los Angeles, California, United States
- UC San Diego — San Diego, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of California, San Francisco — San Francisco, California, United States
- Coastal Integrative Cancer Care — San Luis Obispo, California, United States
- Central Coast Medical Oncology — Santa Maria, California, United States
- Stanford University — Stanford, California, United States
- Rocky Mountain Cancer Centers — Lakewood, Colorado, United States
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- Altus Research — Lake Worth, Florida, United States
- University of Miami Hospital & Clinics Sylvester Comprehensive Cancer Center — Miami, Florida, United States
- Florida Hospital Cancer Institute — Orlando, Florida, United States
- UF Health Cancer Center — Orlando, Florida, United States
- Horizon BioAdvance — Lafayette, Indiana, United States
- Norton Cancer Institute — Louisville, Kentucky, United States
- Johns Hopkins Kimmel Cancer Center — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Comprehensive Cancer Centers of Nevada — Henderson, Nevada, United States
- Women's Cancer Care Associates — Albany, New York, United States
- Providence Alaska Medical Center — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.